NDC properties for "0.8 ML Simlandi 100 MG/ML Auto-Injector" (RxCUI 2706645)
About this data
The tables show NDC propoerties for 0.8 ML Simlandi 100 MG/ML Auto-Injector with the RxCUI 2706645
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.8 ML Simlandi 100 MG/ML Auto-Injector (RxCUI 2706645)
| BLA | BLA761299 |
|---|---|
| MMSL_CODE | BD41103 |
| RxCUI | 2706645 |
| SPL_SET_ID | 12f609c9-2088-bb05-e063-6394a90a9ecc |
| Prescribable Synonym | Simlandi 80 MG in 0.8 ML Auto-Injector |
| RXNAV_STR | 0.8 ML Simlandi 100 MG/ML Auto-Injector |
| RxNorm Name | 0.8 ML adalimumab-ryvk 100 MG/ML Auto-Injector [Simlandi] |
| RxNorm Synonym | 0.8 ML Simlandi 100 MG/ML Auto-Injector |
| RxNorm Synonym | Simlandi 80 MG per 0.8 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2706645) |
NDC Properties
NDC Item 51759027417
| NDC 9 | 51759-274 |
|---|---|
| NDC 10 | 51759-274-17 |
| NDC Item | 51759027417 |
| Packaging | 1 KIT in 1 CARTON (51759-274-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * .4 mL in 1 POUCH |
| BLA | BLA761299 |
| FDA SPL set id | 864550 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-14 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-274 |
NDC Item 51759038421
| NDC 9 | 51759-384 |
|---|---|
| NDC 10 | 51759-384-21 |
| NDC Item | 51759038421 |
| Related queries | Properties for NDC 9 51759-384 |
NDC Item 51759027417
| NDC 9 | 51759-274 |
|---|---|
| NDC 10 | 51759-274-17 |
| NDC Item | 51759027417 |
| Packaging | 1 KIT in 1 CARTON (51759-274-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * .4 mL in 1 POUCH |
| BLA | BLA761299 |
| FDA SPL set id | 864550 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-14 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-274 |
NDC Item 51759038421
| NDC 9 | 51759-384 |
|---|---|
| NDC 10 | 51759-384-21 |
| NDC Item | 51759038421 |
| Related queries | Properties for NDC 9 51759-384 |